NCT06421259尚未招募不适用
To Switch or Not to Switch to CAB/RPV in PLWH With Past HBV Infection? Risk of HBV Reactivation? A Need for New HBV Markers?
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Risk of HBV reactivation under injectable HIV ART
研究概览
简要总结
In order to assess the risk of hepatitis B reactivation in people living with HIV and undergoing injection therapy, we propose to carry out a descriptive analysis of the evolution of hepatitis B markers in this population.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HIV infected patients under injectable ART
排除标准
- •Active HBV infection
结局指标
主要结局
Risk of HBV reactivation under injectable HIV ART
时间窗: From start of injectable HIV treatment to hepatitis B reactivation, assessed up to 24 months
HBV serology, DNA HBV levels
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVHIV InfectionsHepatitis BNCT00033163National Institute of Allergy and Infectious Diseases (NIAID)90
已完成
3 期
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .HIVHepatitis BNCT02003703Universidad de Valparaiso107
Unknown
4 期
Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected PatientsHepatitis B VaccineNCT03962803Shanxi Medical University300
已完成
2 期
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesHIVCommunicable DiseasesHBVInfectious DiseasesHepatitis BNCT02434848Sheffield Teaching Hospitals NHS Foundation Trust13
Unknown
不适用
Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive PatientsHIVNCT01437475Tel-Aviv Sourasky Medical Center100